Clinical Trial Update: Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial results for NNC109-0012 in active rheumatoid arthritis were reported. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• NNC109-0012

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Inflammation, Rheumatoid Arthritis | Phase 2 | Status: COMPLETED